These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 22815287)

  • 21. Mammary gland development requires syndecan-1 to create a beta-catenin/TCF-responsive mammary epithelial subpopulation.
    Liu BY; Kim YC; Leatherberry V; Cowin P; Alexander CM
    Oncogene; 2003 Dec; 22(58):9243-53. PubMed ID: 14681683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of p38 mitogen-activated protein kinase drives dendritic cells to become tolerogenic in ret transgenic mice spontaneously developing melanoma.
    Zhao F; Falk C; Osen W; Kato M; Schadendorf D; Umansky V
    Clin Cancer Res; 2009 Jul; 15(13):4382-90. PubMed ID: 19549770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of casein kinase 1alpha in melanoma cells induces a switch in beta-catenin signaling to promote metastasis.
    Sinnberg T; Menzel M; Kaesler S; Biedermann T; Sauer B; Nahnsen S; Schwarz M; Garbe C; Schittek B
    Cancer Res; 2010 Sep; 70(17):6999-7009. PubMed ID: 20699366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mastermind-like 1 Is a specific coactivator of beta-catenin transcription activation and is essential for colon carcinoma cell survival.
    Alves-Guerra MC; Ronchini C; Capobianco AJ
    Cancer Res; 2007 Sep; 67(18):8690-8. PubMed ID: 17875709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Specific immune against pancreatic cancer induced by dendritic cells pulsed with mutant K-ras peptide].
    Yang B; He Y; Sun DL; Zou Y; Qin XH; Huang BH
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1956-60. PubMed ID: 19062734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced cancer immunotherapy using STAT3-depleted dendritic cells with high Th1-inducing ability and resistance to cancer cell-derived inhibitory factors.
    Iwata-Kajihara T; Sumimoto H; Kawamura N; Ueda R; Takahashi T; Mizuguchi H; Miyagishi M; Takeda K; Kawakami Y
    J Immunol; 2011 Jul; 187(1):27-36. PubMed ID: 21632716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effective treatment of tumors with strong beta-catenin/T-cell factor activity by transcriptionally targeted oncolytic herpes simplex virus vector.
    Kuroda T; Rabkin SD; Martuza RL
    Cancer Res; 2006 Oct; 66(20):10127-35. PubMed ID: 17047077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SKI activates Wnt/beta-catenin signaling in human melanoma.
    Chen D; Xu W; Bales E; Colmenares C; Conacci-Sorrell M; Ishii S; Stavnezer E; Campisi J; Fisher DE; Ben-Ze'ev A; Medrano EE
    Cancer Res; 2003 Oct; 63(20):6626-34. PubMed ID: 14583455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential requirements for β-catenin during mouse development.
    Rudloff S; Kemler R
    Development; 2012 Oct; 139(20):3711-21. PubMed ID: 22991437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wnt induction of chondrocyte hypertrophy through the Runx2 transcription factor.
    Dong YF; Soung do Y; Schwarz EM; O'Keefe RJ; Drissi H
    J Cell Physiol; 2006 Jul; 208(1):77-86. PubMed ID: 16575901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preclinical evaluation of destruxin B as a novel Wnt signaling target suppressing proliferation and metastasis of colorectal cancer using non-invasive bioluminescence imaging.
    Yeh CT; Rao YK; Ye M; Wu WS; Chang TC; Wang LS; Wu CH; Wu AT; Tzeng YM
    Toxicol Appl Pharmacol; 2012 May; 261(1):31-41. PubMed ID: 22465936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melanoma-Derived Wnt5a Promotes Local Dendritic-Cell Expression of IDO and Immunotolerance: Opportunities for Pharmacologic Enhancement of Immunotherapy.
    Holtzhausen A; Zhao F; Evans KS; Tsutsui M; Orabona C; Tyler DS; Hanks BA
    Cancer Immunol Res; 2015 Sep; 3(9):1082-95. PubMed ID: 26041736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Wnt/β-catenin pathway attenuates experimental allergic airway disease.
    Reuter S; Martin H; Beckert H; Bros M; Montermann E; Belz C; Heinz A; Ohngemach S; Sahin U; Stassen M; Buhl R; Eshkind L; Taube C
    J Immunol; 2014 Jul; 193(2):485-95. PubMed ID: 24929002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wnt-β-Catenin Signaling in Human Dendritic Cells Mediates Regulatory T-Cell Responses to Fungi via the PD-L1 Pathway.
    Karnam A; Bonam SR; Rambabu N; Wong SSW; Aimanianda V; Bayry J
    mBio; 2021 Dec; 12(6):e0282421. PubMed ID: 34781737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro and in vivo anti-tumor activity of CoQ0 against melanoma cells: inhibition of metastasis and induction of cell-cycle arrest and apoptosis through modulation of Wnt/β-catenin signaling pathways.
    Hseu YC; Thiyagarajan V; Tsou HT; Lin KY; Chen HJ; Lin CM; Liao JW; Yang HL
    Oncotarget; 2016 Apr; 7(16):22409-26. PubMed ID: 26968952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. WNT/β-Catenin Signaling Pathway Regulating T Cell-Inflammation in the Tumor Microenvironment.
    Li X; Xiang Y; Li F; Yin C; Li B; Ke X
    Front Immunol; 2019; 10():2293. PubMed ID: 31616443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The regulatory role of Wnt signaling pathway in the proliferation and activation of memory T cells].
    Luo L; Luo G; Fang Q; Huang S; Chen H
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Dec; 32(12):1595-1599. PubMed ID: 27916087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin D-VDR Signaling Inhibits Wnt/β-Catenin-Mediated Melanoma Progression and Promotes Antitumor Immunity.
    Muralidhar S; Filia A; Nsengimana J; Poźniak J; O'Shea SJ; Diaz JM; Harland M; Randerson-Moor JA; Reichrath J; Laye JP; van der Weyden L; Adams DJ; Bishop DT; Newton-Bishop J
    Cancer Res; 2019 Dec; 79(23):5986-5998. PubMed ID: 31690667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activating the Wnt/β-Catenin Pathway for the Treatment of Melanoma--Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3.
    Atkinson JM; Rank KB; Zeng Y; Capen A; Yadav V; Manro JR; Engler TA; Chedid M
    PLoS One; 2015; 10(4):e0125028. PubMed ID: 25915038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. REGγ accelerates melanoma formation by regulating Wnt/β-catenin signalling pathway.
    Chen H; Gao X; Sun Z; Wang Q; Zuo D; Pan L; Li K; Chen J; Chen G; Hu K; Li K; Shah AS; Huang T; Muhammad Zeeshan B; Tong L; Jiao C; Liu J; Chen T; Yao L; Dang Y; Liu T; Li L
    Exp Dermatol; 2017 Nov; 26(11):1118-1124. PubMed ID: 28605165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.